CFTR c.1860T>G ;(p.H620Q)

Variant ID: 7-117232081-T-G

NM_000492.3(CFTR):c.1860T>G;(p.H620Q)

This variant was identified in 7 publications

View GRCh38 version.




Publications:


GESPA: classifying nsSNPs to predict disease association.

Bmc Bioinformatics
Khurana, Jay K JK; Reeder, Jay E JE; Shrimpton, Antony E AE; Thakar, Juilee J
Publication Date: 2015-07-25

Variant appearance in text: CFTR: H620Q
PubMed Link: 26206375
Variant Present in the following documents:
  • 12859_2015_673_MOESM1_ESM.xls, sheet 4
View BVdb publication page



Enhancing the Potency of F508del Correction: A Multi-Layer Combinational Approach to Drug Discovery for Cystic Fibrosis.

Journal Of Pharmacology & Clinical Toxicology
Kirby, Emily F EF; Heard, Ashley S AS; Wang, X Robert XR
Publication Date: 2013-08-28

Variant appearance in text: CFTR: H620Q
PubMed Link: 24855632
Variant Present in the following documents:
  • Main text
View BVdb publication page



Structural changes of CFTR R region upon phosphorylation: a plastic platform for intramolecular and intermolecular interactions.

The Febs Journal
Bozoky, Zoltan Z; Krzeminski, Mickael M; Chong, P Andrew PA; Forman-Kay, Julie D JD
Publication Date: 2013-09

Variant appearance in text: CFTR: H620Q
PubMed Link: 23826884
Variant Present in the following documents:
  • Main text
  • febs-280-4407.pdf
View BVdb publication page



Conformational changes relevant to channel activity and folding within the first nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator.

The Journal Of Biological Chemistry
Hudson, Rhea P RP; Chong, P Andrew PA; Protasevich, Irina I II; Vernon, Robert R; Noy, Efrat E; Bihler, Hermann H; An, Jian Li JL; Kalid, Ori O; Sela-Culang, Inbal I; Mense, Martin M; Senderowitz, Hanoch H; Brouillette, Christie G CG; Forman-Kay, Julie D JD
Publication Date: 2012-08-17

Variant appearance in text: CFTR: H620Q
PubMed Link: 22722932
Variant Present in the following documents:
  • Main text
View BVdb publication page



Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients.

Respiratory Research
Green, Deanna M DM; McDougal, Kathryn E KE; Blackman, Scott M SM; Sosnay, Patrick R PR; Henderson, Lindsay B LB; Naughton, Kathleen M KM; Collaco, J Michael JM; Cutting, Garry R GR
Publication Date: 2010-10-08

Variant appearance in text: CFTR: H620Q
PubMed Link: 20932301
Variant Present in the following documents:
  • Main text
  • 1465-9921-11-140.pdf
View BVdb publication page



C terminus of nucleotide binding domain 1 contains critical features for cystic fibrosis transmembrane conductance regulator trafficking and activation.

The Journal Of Biological Chemistry
Billet, Arnaud A; Melin, Patricia P; Jollivet, Mathilde M; Mornon, Jean-Paul JP; Callebaut, Isabelle I; Becq, Frédéric F
Publication Date: 2010-07-16

Variant appearance in text: CFTR: H620Q
PubMed Link: 20435887
Variant Present in the following documents:
  • Main text
View BVdb publication page



Aberrant CFTR-dependent HCO3- transport in mutations associated with cystic fibrosis.

Nature
Choi, J Y JY; Muallem, D D; Kiselyov, K K; Lee, M G MG; Thomas, P J PJ; Muallem, S S
Publication Date: 2001-03-01

Variant appearance in text: CFTR: H620Q
PubMed Link: 11242048
Variant Present in the following documents:
  • Main text
View BVdb publication page